E-Mail
IMAGE: UNC LIneberger s Matthew Painschab, MD, and colleagues report in Lancet Global Health that they have demonstrated in a clinical trial in Malawi that a five-drug combination chemotherapy provided curative benefit. view more
Credit: UNC School of Medicine
CHAPEL HILL, North Carolina Researchers at the UNC Lineberger Comprehensive Cancer Center demonstrated in a clinical trial in Malawi that a five-drug combination chemotherapy provided curative benefit compared to current standard-of care-therapy in people diagnosed with lymphoma, and now they have determined this option is also cost-effective. The economic finding appeared July 22, 2021, in
Lancet Global Health.
The clinical trial results, reported May 19, 2021, in